Berkshire Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,090
Closed -$376K 151
2023
Q4
$376K Hold
3,090
0.1% 111
2023
Q3
$347K Hold
3,090
0.1% 110
2023
Q2
$450K Hold
3,090
0.12% 98
2023
Q1
$399K Hold
3,090
0.12% 99
2022
Q4
$394K Sell
3,090
-80
-3% -$9.28K 0.12% 99
2022
Q3
$332K Hold
3,170
0.1% 107
2022
Q2
$333K Sell
3,170
-623
-16% -$73.9K 0.1% 105
2022
Q1
$486K Sell
3,793
-114
-3% -$13.7K 0.12% 93
2021
Q4
$482K Hold
3,907
0.11% 97
2021
Q3
$555K Hold
3,907
0.14% 92
2021
Q2
$610K Sell
3,907
-51
-1% -$8.26K 0.15% 90
2021
Q1
$615K Sell
3,958
-83
-2% -$12.9K 0.15% 91
2020
Q4
$604K Hold
4,041
0.15% 90
2020
Q3
$534K Buy
+4,041
New +$528K 0.14% 90

Other funds holding ZBH

Berkshire Bank's ZBH Position: Q1 2024 in Review

Berkshire Bank sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 3,090 shares — an estimated $376K sold.

Berkshire Bank first reported a position in ZBH in Q3 2020 and held it in 14 quarters. The position peaked at $615K in Q1 2021. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Berkshire Bank reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Berkshire Bank sold 3,090 Zimmer Biomet shares in Q1 2024, an estimated $376K.
  • Berkshire Bank first reported a position in Zimmer Biomet in Q3 2020 and held it in 14 quarters.
  • Berkshire Bank's Zimmer Biomet position peaked at $615K in Q1 2021.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Berkshire Bank's 13F filing for Q1 2024, filed 24 Apr 2024.